behavior/neurological
• mild incoordination noticeable by 12 months of age
|
immune system
• in splenocytes at 2 weeks of age
|
• in splenocytes at 2 weeks of age
|
• in splenocytes at 2 weeks and 2 years of age
|
• in splenocytes at 2 weeks, 4 weeks, and 2 years of age
|
• in splenocytes at 2 weeks of age
|
• in splenocytes at 2 weeks of age
|
homeostasis/metabolism
• exhibit elevated blood levels of creatine kinase
|
• exhibit elevated blood levels of pyruvate kinase
|
muscle
• development of electron-dense bodies in the mitochondria resulting in swelling and degenerating mitochondria, and disruption of the plasmalemma basal lamina
• the normal myofibrillar architecture of bands and lines disappears and myofilaments disintegrate and become misaligned
|
• variable muscle fiber size; progressive starting at 3 weeks of age
|
• exhibit mild muscle fibrosis, however there is no replacement of lost muscle by fat cells
|
• progressive starting at 9 weeks of age
|
• progressive starting at 3 weeks of age
|
• progressive starting at 3 weeks of age
|
• increased intracellular sodium concentration in muscle; increased severity with age
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Duchenne muscular dystrophy | DOID:11723 |
OMIM:310200 |
J:7361 |